Compare, Analyse Dr. Reddys with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs MYLAN (US) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   MYLAN
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
MYLAN
Dec-18
DR. REDDYS LAB/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3,3633,554-   
Low Rs2,3521,956-   
Sales per share (Unadj.) Rs1,054.21,635.5-  
Earnings per share (Unadj.) Rs121.944.4-  
Cash flow per share (Unadj.) Rs190.2350.6-  
Dividends per share (Unadj.) Rs25.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs938.71,769.3-  
Shares outstanding (eoy) m166.17514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.71.7 160.9%   
Avg P/E ratio x23.462.0 37.8%  
P/CF ratio (eoy) x15.07.9 191.2%  
Price / Book Value ratio x3.01.6 195.5%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m474,8311,417,614 33.5%   
No. of employees `00021.735.0 61.9%   
Total wages/salary Rs m33,8020-   
Avg. sales/employee Rs Th8,091.024,041.6 33.7%   
Avg. wages/employee Rs Th1,561.30-   
Avg. net profit/employee Rs Th935.8652.8 143.3%   
INCOME DATA
Net Sales Rs m175,170841,456 20.8%  
Other income Rs m6,2060-   
Total revenues Rs m181,376841,456 21.6%   
Gross profit Rs m24,421217,738 11.2%  
Depreciation Rs m11,348157,554 7.2%   
Interest Rs m98340,471 2.4%   
Profit before tax Rs m18,29619,713 92.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,403-3,136 44.7%   
Profit after tax Rs m20,26022,849 88.7%  
Gross profit margin %13.925.9 53.9%  
Effective tax rate %-7.7-15.9 48.2%   
Net profit margin %11.62.7 425.9%  
BALANCE SHEET DATA
Current assets Rs m125,991469,868 26.8%   
Current liabilities Rs m72,141342,586 21.1%   
Net working cap to sales %30.715.1 203.2%  
Current ratio x1.71.4 127.3%  
Inventory Days Days7384 87.4%  
Debtors Days Days10593 112.3%  
Net fixed assets Rs m83,854163,229 51.4%   
Share capital Rs m831448 185.5%   
"Free" reserves Rs m155,1570-   
Net worth Rs m155,988910,302 17.1%   
Long term debt Rs m1,304982,508 0.1%   
Total assets Rs m232,2532,441,784 9.5%  
Interest coverage x19.61.5 1,318.8%   
Debt to equity ratio x01.1 0.8%  
Sales to assets ratio x0.80.3 218.9%   
Return on assets %9.12.6 352.7%  
Return on equity %13.02.5 517.4%  
Return on capital %12.63.2 396.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m44,5770-   
CASH FLOW
From Operations Rs m29,841174,855 17.1%  
From Investments Rs m-4,923-90,381 5.4%  
From Financial Activity Rs m-25,159-81,458 30.9%  
Net Cashflow Rs m-2661,449 -18.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.67 Rs / USD

Compare DR. REDDYS LAB With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: TTK HEALTHCARE  PANACEA BIOTECH  JUBILANT PHARMOVA   STERLING BIOTECH  AJANTA PHARMA  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views On News

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. REDDYS LAB SHARE PRICE


Apr 9, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS